The development of new drugs is a lengthy and resource-intensive process, often spanning decades and requiring substantial financial investment and effort. With success rates typically low, hovering around 14%, the need to streamline this process, reduce costs, and enhance success rates is paramount. Drug repurposing e...
A. Pargaien, Mansi Adhikari, A. Rana et al.· Challenges in Information, C...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.